Finance

Lists
Why is NEOG down ၂.၂၅%?
Dive Deeper
NEOG:NASDAQ
Neogen Corp
၁၁.၇၃ US$
-၂.၂၅%
(-၀.၂၇) 1D
၁၁.၈၅ US$
+၁.၀၂% (+၀.၁၂)
Pre-market
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEOG...
Open
၁၁.၉၉ US$
High
၁၂.၀၆ US$
Low
၁၁.၇၁ US$
Mkt. cap
၂၅၆.၀၇ ဋေ
Avg. vol.
၄.၅၅ သန်း
Volume
၁၀၁.၀၀
52-wk high
၁၄.၁၈ US$
52-wk low
၅.၃၇ US$
EPS
-၀.၂၆ US$
Beta
၁.၇၉
Shares outstanding
၂၁.၈၃ ကုဋေ
No. of employees
၃ ထောင်
Open
၁၁.၉၉ US$
High
၁၂.၀၆ US$
Low
၁၁.၇၁ US$
Mkt. cap
၂၅၆.၀၇ ဋေ
Avg. vol.
၄.၅၅ သန်း
Volume
၁၀၁.၀၀
52-wk high
၁၄.၁၈ US$
52-wk low
၅.၃၇ US$
EPS
-၀.၂၆ US$
Beta
၁.၇၉
Shares outstanding
၂၁.၈၃ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
ပြီးခဲ့သည့် ၁ ရက်
Understanding Momentum Shifts in (NEOG)
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၁ ပတ်
NEOG Q3 2026 Earnings: Narrower-Than-Expected Loss Delivers 24.59% EPS Beat - Energy Earnings Report
Profile
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues. Wikipedia
About Neogen Corp
CEOJohn Adent
Employees၂.၆၄ ထောင်
Founded၁၉၈၂
Headquarters-
Sector-
Websiteneogen.com
Analyst ratings
Based on 3 analysts giving stock ratings to NEOG in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NEOG in the last 3 months.
Highest
Current ၁၁.၇၃ US$
၁၄.၀၀ US$ (+၁၉.၃၅%)
Average
၁၄.၀၀ US$ (+၁၉.၃၅%)
Lowest
၁၄.၀၀ US$ (+၁၉.၃၅%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Maintained
၁၄.၀၀ US$
+၁၉.၄%
10/07/2026
Subbu Nambi
Guggenheim
Buy
Maintained
၁၄.၀၀ US$
+၁၉.၄%
09/29/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
09/28/2026
Last report
၂၀၂၆ အောက် ၆
Fiscal period
Q1 2027
၀.၀၈ US$ / ၀.၀၅ US$
+၅၀.၀၁%beat
Revenue / Est. (USD)
၂၂.၂၈ ကုဋေ / ၂၀.၈၂ ကုဋေ
+၇.၀၃%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ နို
၂၀၂၆ ဖေ
၂၀၂၆ မေ
၂၀၂၆ ဩ
Revenue
၂၂.၄၇ ကုဋေ
၂၁.၁၂ ကုဋေ
၂၂.၅၃ ကုဋေ
၂၂.၂၈ ကုဋေ
Cost of goods sold
၁၁.၈၀ ကုဋေ
၁၁.၂၂ ကုဋေ
၁၁.၇၅ ကုဋေ
၁၁.၇၃ ကုဋေ
Cost of revenue
၁၁.၈၀ ကုဋေ
၁၁.၂၂ ကုဋေ
၁၁.၇၅ ကုဋေ
၁၁.၇၃ ကုဋေ
Research and development expenses
၄.၅၆ သန်း
၃.၈၀ သန်း
၄.၉၀ သန်း
၆.၅၀ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၀.၇၅ ကုဋေ
၉.၈၅ ကုဋေ
၉.၉၈ ကုဋေ
၁၀.၀၈ ကုဋေ
Operating expense
၁၁.၂၁ ကုဋေ
၁၀.၂၃ ကုဋေ
၁၀.၄၇ ကုဋေ
၁၀.၇၃ ကုဋေ
Total operating expenses
၂၃.၀၁ ကုဋေ
၂၁.၄၅ ကုဋေ
၂၂.၂၂ ကုဋေ
၂၂.၄၆ ကုဋေ
Operating income
-၅.၃၈ သန်း
-၃.၃၀ သန်း
၃.၁၀ သန်း
-၁.၈၀ သန်း
Other non operating income
-၄.၇၇ သိန်း
-၃.၁၀ သန်း
၄.၅၀ သန်း
၁.၄၀ သန်း
EBT including unusual items
-၂.၀၄ ကုဋေ
-၂.၀၃ ကုဋေ
-၁.၂၁ ကုဋေ
-၁.၄၉ ကုဋေ
EBT excluding unusual items
-၂.၀၄ ကုဋေ
-၂.၀၃ ကုဋေ
-၁.၂၁ ကုဋေ
-၁.၄၅ ကုဋေ
Income tax expense
-၄.၄၄ သန်း
-၃.၃၀ သန်း
-၈.၀၀ သိန်း
-၃.၀၀ သန်း
Effective tax rate
၂၁.၈၀%
၁၆.၂၆%
၆.၆၁%
၂၀.၁၃%
Other operating expenses
-
-
-
-
Net income
-၁.၅၉ ကုဋေ
-၁.၇၀ ကုဋေ
-၁.၁၃ ကုဋေ
-၁.၁၉ ကုဋေ
Net profit margin
-၇.၀၉%
-၈.၀၅%
-၅.၀၂%
-၅.၃၄%
Earnings per share
၀.၁၀
၀.၀၉
၀.၀၉
၀.၀၈
Interest and investment income
၅.၉၂ သိန်း
-
-
-
Interest expense
-၁.၄၈ ကုဋေ
-၁.၃၉ ကုဋေ
-၁.၃၉ ကုဋေ
-၁.၃၈ ကုဋေ
Net interest expenses
-၁.၄၃ ကုဋေ
-၁.၃၉ ကုဋေ
-၁.၃၉ ကုဋေ
-၁.၃၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၂.၃၆ ကုဋေ
၂.၅၆ ကုဋေ
၃.၂၅ ကုဋေ
၂.၇၃ ကုဋေ
Gain or loss from assets sale
၂.၆၇ သိန်း
၂.၂၄ သိန်း
-
၅.၀၀ သိန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ